United States Healthcare Equipment & Supplies

Becton Dickinson and Co (BDX)

Track

Becton Dickinson and Co experienced fourteen insider trading transactions over the past ninety days, totaling approximately 1.95 million dollars in sales. No purchases occurred during this period. These divestments by executives, including the CEO, coincide with a 24.6 percent stock price increase, occurring ahead of the most recent August results financiers report.

Active selling signal · Strong

Top insider sells (90, 60d)

Top cluster sells (90, 60d)

Top executive sells (90d)

Featured in screeners

Active selling signal · Strong

Top insider sells

Top cluster sells

Top executive sells

Ticker: BDX Exchange: NYS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

29 activity signals detected for Becton Dickinson and Co

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Becton Dickinson and Co. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Proposed sale 3 Aug 2026

Value US$3,948,319.92 | Price 131.03 | Shares 12,866

Sale 27 Jul 2026

Value US$2,548,083.56 | Price 396.66 | Shares 91,377 (+28.7%)

Proposed sale 27 Jul 2026

Value US$100,000.00 | Price 156.36 | Shares 1,000

Sale 26 Jun 2026

Value US$11,460.00 | Price 152.80 | Shares 75 (-0.4%)

Proposed sale 26 Jun 2026

Value US$11,353.50 | Price 151.38 | Shares 75

Sale 24 Jun 2026

Value US$160,226.00 | Price 145.66 | Shares 1,100 (-7.7%)

Proposed sale 24 Jun 2026

Value US$158,312.00 | Price 143.92 | Shares 1,100

Sale 10 Jun 2026

Value US$166,628.00 | Price 151.48 | Shares 1,100 (-7.2%)

Sale 10 Jun 2026

Value US$166,628.00 | Price 151.48 | Shares 1,100 (-7.2%)

Proposed sale 10 Jun 2026

Value US$167,244.00 | Price 152.04 | Shares 1,100

Sale 1 Jun 2026

Value US$404,511.40 | Price 146.35 | Shares 2,764 (-2.4%)

Proposed sale 1 Jun 2026

Value US$406,639.68 | Price 147.12 | Shares 2,764

Sale 26 May 2026

Value US$11,051.25 | Price 147.35 | Shares 75 (-0.4%)

Proposed sale 26 May 2026

Value US$11,072.25 | Price 147.63 | Shares 75

Sale 27 Apr 2026

Value US$11,243.56 | Price 151.94 | Shares 74 (-0.3%)

Proposed sale 27 Apr 2026

Value US$11,258.36 | Price 152.14 | Shares 74

Planned sale 26 Mar 2026

Value US$11,762.25 | Price 156.83 | Shares 75 (-0.4%)

Proposed sale 26 Mar 2026

Value US$11,870.25 | Price 158.27 | Shares 75

Sale 26 Feb 2026

Value US$13,638.00 | Price 181.84 | Shares 75 (-0.4%)

Proposed sale 26 Feb 2026

Value US$13,572.00 | Price 180.96 | Shares 75

Proposed sale 20 Feb 2026

Value US$998,429.24 | Price 184.14 | Shares 5,422

Proposed sale 20 Feb 2026

Value US$2,079,070.15 | Price 183.91 | Shares 11,305

Sale 18 Feb 2026

Value US$174,027.33 | Price 182.61 | Shares 953 (-2.5%)

Proposed sale 18 Feb 2026

Value US$1,708,885.71 | Price 182.46 | Shares 9,366

Proposed sale 18 Feb 2026

Value US$174,027.33 | Price 182.61 | Shares 953

Sale 26 Jan 2026

Value US$15,204.75 | Price 202.73 | Shares 75 (-0.5%)

Proposed sale 26 Jan 2026

Value US$15,134.25 | Price 201.79 | Shares 75

Sale 15 Jan 2026

Value US$208,605.40 | Price 206.54 | Shares 1,010 (-7.7%)

Sale 15 Jan 2026

Value US$125,400.00 | Price 209.00 | Shares 600 (-4.4%)

Proposed sale 15 Jan 2026

Value US$333,946.20 | Price 207.42 | Shares 1,610

Proposed sale 26 Dec 2025

Value US$14,512.88 | Price 196.12 | Shares 74

Sale 26 Dec 2025

Value US$14,509.92 | Price 196.08 | Shares 74 (-0.4%)

Proposed sale 17 Dec 2025

Value US$123,529.31 | Price 196.39 | Shares 629

Sale 17 Dec 2025

Value US$123,302.87 | Price 196.03 | Shares 629 (-4.6%)

Sale 1 Dec 2025

Value US$14,502.00 | Price 193.36 | Shares 75 (-0.5%)

Proposed sale 1 Dec 2025

Value US$14,551.50 | Price 194.02 | Shares 75

Proposed sale 7 Nov 2025

Value US$38,317.88 | Price 176.58 | Shares 217

Sale 7 Nov 2025

Value US$38,317.86 | Price 176.58 | Shares 217 (-0.6%)

Sale 27 Oct 2025

Value US$10,602.57 | Price 186.01 | Shares 57 (-0.7%)

Proposed sale 27 Oct 2025

Value US$10,592.31 | Price 185.83 | Shares 57

Sale 26 Sep 2025

Value US$10,499.74 | Price 181.03 | Shares 58 (-0.7%)

Proposed sale 26 Sep 2025

Value US$10,474.22 | Price 180.59 | Shares 58

Sale 10 Sep 2025

Value US$171,937.50 | Price 187.50 | Shares 917 (-4.0%)

Proposed sale 10 Sep 2025

Value US$171,862.50 | Price 187.42 | Shares 917

Sale 22 Aug 2025

Value US$11,285.43 | Price 197.99 | Shares 57 (-0.7%)

Proposed sale 22 Aug 2025

Value US$11,207.91 | Price 196.63 | Shares 57

Buy 11 Aug 2025

Value US$1,005,742.50 | Price 191.57 | Shares 5,250 (+659.5%)

Proposed sale 8 Aug 2025

Value US$165,879.90 | Price 192.21 | Shares 863

Sale 8 Aug 2025

Value US$165,954.90 | Price 192.30 | Shares 863 (-3.6%)

Sale 18 Jul 2025

Value US$181.50 | Price 181.50 | Shares 1 (-0.0%)

Sale 18 Jul 2025

Value US$213,463.36 | Price 180.29 | Shares 1,184 (-19.5%)

Proposed sale 18 Jul 2025

Value US$214,366.50 | Price 180.90 | Shares 1,185

Proposed sale 2 Jun 2025

Value US$201,239.94 | Price 172.59 | Shares 1,166

Sale 2 Jun 2025

Value US$199,607.54 | Price 171.19 | Shares 1,166 (-20.3%)

Sale 9 Apr 2025

Value US$94,497.12 | Price 197.28 | Shares 479 (-8.9%)

Proposed sale 9 Apr 2025

Value US$96,197.57 | Price 200.83 | Shares 479

Sale 18 Mar 2025

Value US$105,570.00 | Price 230.00 | Shares 459 (-6.2%)

Proposed sale 18 Mar 2025

Value US$104,573.97 | Price 227.83 | Shares 459

Sale 12 Mar 2025

Value US$436,325.40 | Price 224.91 | Shares 1,940 (-20.7%)

Proposed sale 12 Mar 2025

Value US$436,344.80 | Price 224.92 | Shares 1,940

Proposed sale 12 Feb 2025

Value US$159,593.00 | Price 227.99 | Shares 700

Sale 12 Feb 2025

Value US$159,593.00 | Price 227.99 | Shares 700 (-1.9%)

Buy 10 Feb 2025

Value US$350,430.00 | Price 233.62 | Shares 1,500 (+23.0%)

Sale 21 Jan 2025

Value US$188,880.00 | Price 240.00 | Shares 787 (-4.9%)

Sale 21 Jan 2025

Value US$120,000.00 | Price 240.00 | Shares 500 (-8.0%)

Proposed sale 21 Jan 2025

Value US$186,818.06 | Price 237.38 | Shares 787

Proposed sale 21 Jan 2025

Value US$118,690.00 | Price 237.38 | Shares 500

Sale 17 Jan 2025

Value US$141,196.47 | Price 236.51 | Shares 597 (-9.7%)

Proposed sale 17 Jan 2025

Value US$141,071.10 | Price 236.30 | Shares 597

Sale 7 Jan 2025

Value US$185,180.00 | Price 235.00 | Shares 788 (-4.6%)

Proposed sale 7 Jan 2025

Value US$181,791.60 | Price 230.70 | Shares 788

Sale 19 Dec 2024

Value US$633,810.54 | Price 223.33 | Shares 2,838 (-31.6%)

Proposed sale 19 Dec 2024

Value US$635,967.42 | Price 224.09 | Shares 2,838

Sale 9 Dec 2024

Value US$139,741.14 | Price 219.03 | Shares 638 (-4.3%)

Proposed sale 9 Dec 2024

Value US$140,372.76 | Price 220.02 | Shares 638

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-08-03	2026-08-03	PrS Proposed sale	3.1 SHANA NEAL Officer Officer	12,866 131.03 US$3,948,320	12,866	131.03	US$3,948,320
2026-07-28	2026-07-27	S Sale	2.8 Feld Michael EVP, Chief Revenue Officer Officer	91,377 +28.7% 396.66 US$2,548,084	91,377 +28.7%	396.66	US$2,548,084
2026-07-27	2026-07-27	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	63,772 237.72 US$4,216,904	63,772	237.72	US$4,216,904
2026-06-26	2026-06-26	S Sale	2.8 Feld Michael EVP, Chief Revenue Officer Officer	75 -0.4% 152.80 US$11,460	75 -0.4%	152.80	US$11,460
2026-06-26	2026-06-26	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	75 151.38 US$11,354	75	151.38	US$11,354
2026-06-25	2026-06-24	S Sale	3.1 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer	1,100 -7.7% 145.66 US$160,226	1,100 -7.7%	145.66	US$160,226
2026-06-24	2026-06-24	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	1,100 143.92 US$158,312	1,100	143.92	US$158,312
2026-06-11	2026-06-10	S Sale	3.1 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer	1,100 -7.2% 151.48 US$166,628	1,100 -7.2%	151.48	US$166,628
2026-06-11	2026-06-10	S Sale	3.1 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer	1,100 -7.2% 151.48 US$166,628	1,100 -7.2%	151.48	US$166,628
2026-06-10	2026-06-10	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	1,100 152.04 US$167,244	1,100	152.04	US$167,244
2026-06-03	2026-06-01	S Sale	Polen Thomas E Jr Chairman, CEO and President Executive Director	2,764 -2.4% 146.35 US$404,511	2,764 -2.4%	146.35	US$404,511
2026-06-01	2026-06-01	PrS Proposed sale	THOMAS POLEN Officer Officer	2,764 147.12 US$406,640	2,764	147.12	US$406,640
2026-05-27	2026-05-26	S Sale	2.8 Feld Michael EVP, Chief Revenue Officer Officer	75 -0.4% 147.35 US$11,051	75 -0.4%	147.35	US$11,051
2026-05-26	2026-05-26	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	75 147.63 US$11,072	75	147.63	US$11,072
2026-04-28	2026-04-27	S Sale	2.8 Feld Michael EVP, Chief Revenue Officer Officer	74 -0.3% 151.94 US$11,244	74 -0.3%	151.94	US$11,244
2026-04-27	2026-04-27	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	74 152.14 US$11,258	74	152.14	US$11,258
2026-03-27	2026-03-26	PlS Planned sale	2.8 Feld Michael EVP, Chief Revenue Officer Officer	75 -0.4% 156.83 US$11,762	75 -0.4%	156.83	US$11,762
2026-03-26	2026-03-26	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	75 158.27 US$11,870	75	158.27	US$11,870
2026-02-27	2026-02-26	S Sale	2.8 Feld Michael EVP, Chief Revenue Officer Officer	75 -0.4% 181.84 US$13,638	75 -0.4%	181.84	US$13,638
2026-02-26	2026-02-26	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	75 180.96 US$13,572	75	180.96	US$13,572
2026-02-20	2026-02-20	PrS Proposed sale	2.4 DAVID MICHEL SHAN Former Officer Officer	5,422 184.14 US$998,429	5,422	184.14	US$998,429
2026-02-20	2026-02-20	PrS Proposed sale	CHRISTOPHER DELOREFICE Former Officer Officer	11,305 183.91 US$2,079,070	11,305	183.91	US$2,079,070
2026-02-18	2026-02-18	S Sale	3.0 SCOTT BERTRAM L Non-Executive Director	953 -2.5% 182.61 US$174,027	953 -2.5%	182.61	US$174,027
2026-02-18	2026-02-18	PrS Proposed sale	CHRISTOPHER DELOREFICE Former Officer Officer	9,366 182.46 US$1,708,886	9,366	182.46	US$1,708,886
2026-02-18	2026-02-18	PrS Proposed sale	3.0 BERTRAM SCOTT Director Non-Executive Director	953 182.61 US$174,027	953	182.61	US$174,027
2026-01-28	2026-01-26	S Sale	2.8 Feld Michael EVP, CRO & Pres. Life Sciences Officer	75 -0.5% 202.73 US$15,205	75 -0.5%	202.73	US$15,205
2026-01-26	2026-01-26	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	75 201.79 US$15,134	75	201.79	US$15,134
2026-01-16	2026-01-15	S Sale	3.1 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer	1,010 -7.7% 206.54 US$208,605	1,010 -7.7%	206.54	US$208,605
2026-01-16	2026-01-15	S Sale	3.1 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer	600 -4.4% 209.00 US$125,400	600 -4.4%	209.00	US$125,400
2026-01-15	2026-01-15	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	1,610 207.42 US$333,946	1,610	207.42	US$333,946
2025-12-29	2025-12-26	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	74 196.12 US$14,513	74	196.12	US$14,513
2025-12-29	2025-12-26	S Sale	2.8 Feld Michael EVP, CRO & Pres. Life Sciences Officer	74 -0.4% 196.08 US$14,510	74 -0.4%	196.08	US$14,510
2025-12-17	2025-12-17	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	629 196.39 US$123,529	629	196.39	US$123,529
2025-12-17	2025-12-17	S Sale	3.1 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer	629 -4.6% 196.03 US$123,303	629 -4.6%	196.03	US$123,303
2025-12-02	2025-12-01	S Sale	2.8 Feld Michael EVP, CRO & Pres. Life Sciences Officer	75 -0.5% 193.36 US$14,502	75 -0.5%	193.36	US$14,502
2025-12-01	2025-12-01	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	75 194.02 US$14,552	75	194.02	US$14,552
2025-11-07	2025-11-07	PrS Proposed sale	3.0 BERTRAM SCOTT Officer Officer	217 176.58 US$38,318	217	176.58	US$38,318
2025-11-07	2025-11-07	S Sale	3.0 SCOTT BERTRAM L Non-Executive Director	217 -0.6% 176.58 US$38,318	217 -0.6%	176.58	US$38,318
2025-10-28	2025-10-27	S Sale	2.8 Feld Michael EVP & President, Life Sciences Officer	57 -0.7% 186.01 US$10,603	57 -0.7%	186.01	US$10,603
2025-10-27	2025-10-27	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	57 185.83 US$10,592	57	185.83	US$10,592
2025-09-29	2025-09-26	S Sale	2.8 Feld Michael EVP & President, Life Sciences Officer	58 -0.7% 181.03 US$10,500	58 -0.7%	181.03	US$10,500
2025-09-26	2025-09-26	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	58 180.59 US$10,474	58	180.59	US$10,474
2025-09-11	2025-09-10	S Sale	3.5 Fraser Claire Non-Executive Director	917 -4.0% 187.50 US$171,938	917 -4.0%	187.50	US$171,938
2025-09-10	2025-09-10	PrS Proposed sale	3.5 Fraser Claire Director Non-Executive Director	917 187.42 US$171,862	917	187.42	US$171,862
2025-08-26	2025-08-22	S Sale	2.8 Feld Michael EVP & President, Life Sciences Officer	57 -0.7% 197.99 US$11,285	57 -0.7%	197.99	US$11,285
2025-08-22	2025-08-22	PrS Proposed sale	2.8 MICHAEL FELD Officer Officer	57 196.63 US$11,208	57	196.63	US$11,208
2025-08-11	2025-08-11	B Purchase	3.5 HAYES GREGORY Non-Executive Director	5,250 +659.5% 191.57 US$1,005,742	5,250 +659.5%	191.57	US$1,005,742
2025-08-08	2025-08-08	PrS Proposed sale	3.5 Fraser Claire Director Non-Executive Director	863 192.21 US$165,880	863	192.21	US$165,880
2025-08-08	2025-08-08	S Sale	3.5 Fraser Claire Non-Executive Director	863 -3.6% 192.30 US$165,955	863 -3.6%	192.30	US$165,955
2025-07-22	2025-07-18	S Sale	3.1 Garrison Michael David EVP & President, Medical Officer	1 -0.0% 181.50 US$182	1 -0.0%	181.50	US$182
2025-07-22	2025-07-18	S Sale	3.1 Garrison Michael David EVP & President, Medical Officer	1,184 -19.5% 180.29 US$213,463	1,184 -19.5%	180.29	US$213,463
2025-07-18	2025-07-18	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	1,185 180.90 US$214,366	1,185	180.90	US$214,366
2025-06-02	2025-06-02	PrS Proposed sale	2.4 DAVID SHAN Officer Officer	1,166 172.59 US$201,240	1,166	172.59	US$201,240
2025-06-02	2025-06-02	S Sale	2.4 Shan David EVP and Chief ISC Officer Officer	1,166 -20.3% 171.19 US$199,608	1,166 -20.3%	171.19	US$199,608
2025-04-10	2025-04-09	S Sale	3.1 Garrison Michael David EVP & President, Medical Officer	479 -8.9% 197.28 US$94,497	479 -8.9%	197.28	US$94,497
2025-04-09	2025-04-09	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	479 200.83 US$96,198	479	200.83	US$96,198
2025-03-19	2025-03-18	S Sale	3.2 Byrd Richard EVP & President Interventional Officer	459 -6.2% 230.00 US$105,570	459 -6.2%	230.00	US$105,570
2025-03-18	2025-03-18	PrS Proposed sale	3.2 RICHARD BYRD Officer Officer	459 227.83 US$104,574	459	227.83	US$104,574
2025-03-13	2025-03-12	S Sale	3.2 Byrd Richard EVP & President Interventional Officer	1,940 -20.7% 224.91 US$436,325	1,940 -20.7%	224.91	US$436,325
2025-03-12	2025-03-12	PrS Proposed sale	3.2 RICHARD BYRD Officer Officer	1,940 224.92 US$436,345	1,940	224.92	US$436,345
2025-02-12	2025-02-12	PrS Proposed sale	3.0 BERTRAM SCOTT Director Non-Executive Director	700 227.99 US$159,593	700	227.99	US$159,593
2025-02-12	2025-02-12	S Sale	3.0 SCOTT BERTRAM L Non-Executive Director	700 -1.9% 227.99 US$159,593	700 -1.9%	227.99	US$159,593
2025-02-10	2025-02-10	B Purchase	2.9 Henderson Jeffrey William Non-Executive Director	1,500 +23.0% 233.62 US$350,430	1,500 +23.0%	233.62	US$350,430
2025-01-22	2025-01-21	S Sale	3.1 Neal Shana Carol EVP and Chief People Officer Officer	787 -4.9% 240.00 US$188,880	787 -4.9%	240.00	US$188,880
2025-01-22	2025-01-21	S Sale	2.4 Shan David EVP and Chief ISC Officer Officer	500 -8.0% 240.00 US$120,000	500 -8.0%	240.00	US$120,000
2025-01-21	2025-01-21	PrS Proposed sale	3.1 SHANA NEAL Officer Officer	787 237.38 US$186,818	787	237.38	US$186,818
2025-01-21	2025-01-21	PrS Proposed sale	2.4 DAVID SHAN Officer Officer	500 237.38 US$118,690	500	237.38	US$118,690
2025-01-21	2025-01-17	S Sale	3.1 Garrison Michael David EVP & President, Medical Officer	597 -9.7% 236.51 US$141,196	597 -9.7%	236.51	US$141,196
2025-01-17	2025-01-17	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	597 236.30 US$141,071	597	236.30	US$141,071
2025-01-10	2025-01-07	S Sale	3.1 Neal Shana Carol EVP and Chief People Officer Officer	788 -4.6% 235.00 US$185,180	788 -4.6%	235.00	US$185,180
2025-01-07	2025-01-07	PrS Proposed sale	3.1 SHANA NEAL Officer Officer	788 230.70 US$181,792	788	230.70	US$181,792
2024-12-20	2024-12-19	S Sale	3.1 Garrison Michael David EVP & President, Medical Officer	2,838 -31.6% 223.33 US$633,811	2,838 -31.6%	223.33	US$633,811
2024-12-19	2024-12-19	PrS Proposed sale	3.1 MICHAEL GARRISON Officer Officer	2,838 224.09 US$635,967	2,838	224.09	US$635,967
2024-12-10	2024-12-09	S Sale	2.8 Goette Roland EVP and President, EMEA Officer	638 -4.3% 219.03 US$139,741	638 -4.3%	219.03	US$139,741
2024-12-09	2024-12-09	PrS Proposed sale	2.8 ROLAND GOETTE Officer Officer	638 220.02 US$140,373	638	220.02	US$140,373